Semaglutide injecting pen with lid on a white plate. Senior Correspondent As popular as the latest drugs being touted for weight loss, including Ozempic, Mounjaro, and Wegovy, are on social media, ...

(Reuters) -Amgen will test its obesity drug candidate in patients at risk of weight-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert ...

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment ...

A genetic test may one day predict a child’s risk of obesity in adulthood, paving the way for early interventions. Certain genetic variants can affect how a person’s body stores fat or make them more ...

Virtual primary care platform Hello Alpha has teamed up with Phenomix Sciences, a precision medicine biotechnology company, the companies announced Tuesday. The partnership will give Hello Alpha’s ...

What if we could predict obesity before it ever takes hold? A global team has created a genetic test that forecasts a child’s risk of adult obesity before age five—years before other factors kick in.

The future is uncertain — but your kid’s waistline as an adult might not be. Scientists have developed a groundbreaking test that can identify children as young as five who are at increased risk of ...

The study, published in Nature Medicine, shows that future risk of 18 obesity-related diseases can be predicted using 20 ...

Please provide your email address to receive an email when new articles are posted on . Developed at the Mayo Clinic, the test stratifies patients with obesity into one of four phenotype groups to ...